Selected research
Industry Growth & Trends
Global Automated and Rapid Microbiological Tests Bussiness Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Automated and Rapid Microbiological Tests Bussiness market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Automated and Rapid Microbiological Tests Bussiness is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Automated and Rapid Microbiological Tests Bussiness is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Automated and Rapid Microbiological Tests Bussiness is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Automated and Rapid Microbiological Tests Bussiness market include Thermo Fisher Scientific, Roche, Siemens Healthcare Diagnostics, Sekisui Diagnostics, Remel, Quidel Corporation, Oxoid Limited, Orion Diagnostica Oy and Orasure Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Automated and Rapid Microbiological Tests Bussiness market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Automated and Rapid Microbiological Tests Bussiness market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Automated and Rapid Microbiological Tests Bussiness market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Automated and Rapid Microbiological Tests Bussiness.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Automated and Rapid Microbiological Tests Bussiness market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Automated and Rapid Microbiological Tests Bussiness Market by Company
Thermo Fisher Scientific
Roche
Siemens Healthcare Diagnostics
Sekisui Diagnostics
Remel
Quidel Corporation
Oxoid Limited
Orion Diagnostica Oy
Orasure Technologies
Meridian Biosciences
MedMira
Gen-Probe
Celsis International
Cellabs
Bio-Rad Laboratories
BioMerieux SA
Becton Dickinson and Company
Abbott Laboratories
Automated and Rapid Microbiological Tests Bussiness Segment by Type
Automated Identification & Susceptibility Systems
Automated Tuberculosis Systems
Automated Blood Culture Systems
Streptococcal Infection Rapid Tests
GC/Chlamydia Rapid Tests
Other
Automated and Rapid Microbiological Tests Bussiness Segment by Application
Clinical
Non-Clinical
Automated and Rapid Microbiological Tests Bussiness Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automated and Rapid Microbiological Tests Bussiness market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Automated and Rapid Microbiological Tests Bussiness and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automated and Rapid Microbiological Tests Bussiness.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Automated and Rapid Microbiological Tests Bussiness companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Automated Identification & Susceptibility Systems
- Automated Tuberculosis Systems
- Automated Blood Culture Systems
- Streptococcal Infection Rapid Tests
- GC/Chlamydia Rapid Tests
- Other
Applications
- Clinical
- Non-Clinical
Companies covered
- Thermo Fisher Scientific
- Roche
- Siemens Healthcare Diagnostics
- Sekisui Diagnostics
- Remel
- Quidel Corporation
- Oxoid Limited
- Orion Diagnostica Oy
- Orasure Technologies
- Meridian Biosciences
- MedMira
- Gen-Probe
- Celsis International
- Cellabs
- Bio-Rad Laboratories
- BioMerieux SA
- Becton Dickinson and Company
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Automated and Rapid Microbiological Tests Bussiness Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Automated and Rapid Microbiological Tests Bussiness Market Size by Region (2021-2032)
- 1.4.1 Global Automated and Rapid Microbiological Tests Bussiness Market Size by Region (2021-2026)
- 1.4.2 Global Automated and Rapid Microbiological Tests Bussiness Market Size by Region (2027-2032)
- 1.5 Key Regions Automated and Rapid Microbiological Tests Bussiness Market Size (2021-2032)
- 1.5.1 North America Automated and Rapid Microbiological Tests Bussiness Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Automated and Rapid Microbiological Tests Bussiness Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Automated and Rapid Microbiological Tests Bussiness Market Size Growth Rate (2021-2032)
- 1.5.4 South America Automated and Rapid Microbiological Tests Bussiness Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Automated and Rapid Microbiological Tests Bussiness Market Size Growth Rate (2021-2032)
2 Automated and Rapid Microbiological Tests Bussiness Market by Type
- 2.1 Type Introduction
- 2.1.1 Automated Identification & Susceptibility Systems
- 2.1.2 Automated Tuberculosis Systems
- 2.1.3 Automated Blood Culture Systems
- 2.1.4 Streptococcal Infection Rapid Tests
- 2.1.5 GC/Chlamydia Rapid Tests
- 2.1.6 Other
- 2.2 Global Automated and Rapid Microbiological Tests Bussiness Market Size by Type
- 2.2.1 Global Automated and Rapid Microbiological Tests Bussiness Market Size Overview by Type (2021-2032)
- 2.2.2 Global Automated and Rapid Microbiological Tests Bussiness Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Automated and Rapid Microbiological Tests Bussiness Market Size Forecasted by Type (2027-2032)
- 2.3 Global Automated and Rapid Microbiological Tests Bussiness Market Size by Regions
- 2.3.1 North America Automated and Rapid Microbiological Tests Bussiness Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Automated and Rapid Microbiological Tests Bussiness Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Automated and Rapid Microbiological Tests Bussiness Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Automated and Rapid Microbiological Tests Bussiness Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Automated and Rapid Microbiological Tests Bussiness Market Size Breakdown by Type (2021-2026)
3 Automated and Rapid Microbiological Tests Bussiness Market by Application
- 3.1 Type Introduction
- 3.1.1 Clinical
- 3.1.2 Non-Clinical
- 3.2 Global Automated and Rapid Microbiological Tests Bussiness Market Size by Application
- 3.2.1 Global Automated and Rapid Microbiological Tests Bussiness Market Size Overview by Application (2021-2032)
- 3.2.2 Global Automated and Rapid Microbiological Tests Bussiness Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Automated and Rapid Microbiological Tests Bussiness Market Size Forecasted by Application (2027-2032)
- 3.3 Global Automated and Rapid Microbiological Tests Bussiness Market Size by Regions
- 3.3.1 North America Automated and Rapid Microbiological Tests Bussiness Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Automated and Rapid Microbiological Tests Bussiness Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Automated and Rapid Microbiological Tests Bussiness Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Automated and Rapid Microbiological Tests Bussiness Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Automated and Rapid Microbiological Tests Bussiness Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Automated and Rapid Microbiological Tests Bussiness Industry Trends
- 4.2 Automated and Rapid Microbiological Tests Bussiness Industry Drivers
- 4.3 Automated and Rapid Microbiological Tests Bussiness Industry Opportunities and Challenges
- 4.4 Automated and Rapid Microbiological Tests Bussiness Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Automated and Rapid Microbiological Tests Bussiness Revenue (2021-2026)
- 5.2 Global Automated and Rapid Microbiological Tests Bussiness Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Automated and Rapid Microbiological Tests Bussiness Key Company Headquarters & Area Served
- 5.4 Global Automated and Rapid Microbiological Tests Bussiness Company, Product Type & Application
- 5.5 Global Automated and Rapid Microbiological Tests Bussiness Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Automated and Rapid Microbiological Tests Bussiness Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Automated and Rapid Microbiological Tests Bussiness Players Market Share by Revenue in 2025
- 5.6.3 2025 Automated and Rapid Microbiological Tests Bussiness Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Thermo Fisher Scientific
- 6.1.1 Thermo Fisher Scientific Company Information
- 6.1.2 Thermo Fisher Scientific Business Overview
- 6.1.3 Thermo Fisher Scientific Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Thermo Fisher Scientific Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.1.5 Thermo Fisher Scientific Recent Developments
- 6.2 Roche
- 6.2.1 Roche Company Information
- 6.2.2 Roche Business Overview
- 6.2.3 Roche Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Roche Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.2.5 Roche Recent Developments
- 6.3 Siemens Healthcare Diagnostics
- 6.3.1 Siemens Healthcare Diagnostics Company Information
- 6.3.2 Siemens Healthcare Diagnostics Business Overview
- 6.3.3 Siemens Healthcare Diagnostics Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Siemens Healthcare Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.3.5 Siemens Healthcare Diagnostics Recent Developments
- 6.4 Sekisui Diagnostics
- 6.4.1 Sekisui Diagnostics Company Information
- 6.4.2 Sekisui Diagnostics Business Overview
- 6.4.3 Sekisui Diagnostics Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Sekisui Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.4.5 Sekisui Diagnostics Recent Developments
- 6.5 Remel
- 6.5.1 Remel Company Information
- 6.5.2 Remel Business Overview
- 6.5.3 Remel Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Remel Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.5.5 Remel Recent Developments
- 6.6 Quidel Corporation
- 6.6.1 Quidel Corporation Company Information
- 6.6.2 Quidel Corporation Business Overview
- 6.6.3 Quidel Corporation Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Quidel Corporation Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.6.5 Quidel Corporation Recent Developments
- 6.7 Oxoid Limited
- 6.7.1 Oxoid Limited Company Information
- 6.7.2 Oxoid Limited Business Overview
- 6.7.3 Oxoid Limited Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Oxoid Limited Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.7.5 Oxoid Limited Recent Developments
- 6.8 Orion Diagnostica Oy
- 6.8.1 Orion Diagnostica Oy Company Information
- 6.8.2 Orion Diagnostica Oy Business Overview
- 6.8.3 Orion Diagnostica Oy Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Orion Diagnostica Oy Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.8.5 Orion Diagnostica Oy Recent Developments
- 6.9 Orasure Technologies
- 6.9.1 Orasure Technologies Company Information
- 6.9.2 Orasure Technologies Business Overview
- 6.9.3 Orasure Technologies Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Orasure Technologies Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.9.5 Orasure Technologies Recent Developments
- 6.10 Meridian Biosciences
- 6.10.1 Meridian Biosciences Company Information
- 6.10.2 Meridian Biosciences Business Overview
- 6.10.3 Meridian Biosciences Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Meridian Biosciences Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.10.5 Meridian Biosciences Recent Developments
- 6.11 MedMira
- 6.11.1 MedMira Company Information
- 6.11.2 MedMira Business Overview
- 6.11.3 MedMira Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 MedMira Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.11.5 MedMira Recent Developments
- 6.12 Gen-Probe
- 6.12.1 Gen-Probe Company Information
- 6.12.2 Gen-Probe Business Overview
- 6.12.3 Gen-Probe Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Gen-Probe Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.12.5 Gen-Probe Recent Developments
- 6.13 Celsis International
- 6.13.1 Celsis International Company Information
- 6.13.2 Celsis International Business Overview
- 6.13.3 Celsis International Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Celsis International Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.13.5 Celsis International Recent Developments
- 6.14 Cellabs
- 6.14.1 Cellabs Company Information
- 6.14.2 Cellabs Business Overview
- 6.14.3 Cellabs Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Cellabs Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.14.5 Cellabs Recent Developments
- 6.15 Bio-Rad Laboratories
- 6.15.1 Bio-Rad Laboratories Company Information
- 6.15.2 Bio-Rad Laboratories Business Overview
- 6.15.3 Bio-Rad Laboratories Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Bio-Rad Laboratories Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.15.5 Bio-Rad Laboratories Recent Developments
- 6.16 BioMerieux SA
- 6.16.1 BioMerieux SA Company Information
- 6.16.2 BioMerieux SA Business Overview
- 6.16.3 BioMerieux SA Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 BioMerieux SA Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.16.5 BioMerieux SA Recent Developments
- 6.17 Becton Dickinson and Company
- 6.17.1 Becton Dickinson and Company Company Information
- 6.17.2 Becton Dickinson and Company Business Overview
- 6.17.3 Becton Dickinson and Company Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Becton Dickinson and Company Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.17.5 Becton Dickinson and Company Recent Developments
- 6.18 Abbott Laboratories
- 6.18.1 Abbott Laboratories Company Information
- 6.18.2 Abbott Laboratories Business Overview
- 6.18.3 Abbott Laboratories Automated and Rapid Microbiological Tests Bussiness Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Abbott Laboratories Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 6.18.5 Abbott Laboratories Recent Developments
7 North America
- 7.1 North America Automated and Rapid Microbiological Tests Bussiness Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Automated and Rapid Microbiological Tests Bussiness Market Size by Country (2021-2026)
- 7.3 North America Automated and Rapid Microbiological Tests Bussiness Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Automated and Rapid Microbiological Tests Bussiness Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Automated and Rapid Microbiological Tests Bussiness Market Size by Country (2021-2026)
- 8.3 Europe Automated and Rapid Microbiological Tests Bussiness Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Automated and Rapid Microbiological Tests Bussiness Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Automated and Rapid Microbiological Tests Bussiness Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Automated and Rapid Microbiological Tests Bussiness Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Automated and Rapid Microbiological Tests Bussiness Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Automated and Rapid Microbiological Tests Bussiness Market Size by Country (2021-2026)
- 10.3 South America Automated and Rapid Microbiological Tests Bussiness Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Automated and Rapid Microbiological Tests Bussiness Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Automated and Rapid Microbiological Tests Bussiness Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Automated and Rapid Microbiological Tests Bussiness Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst